CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,000 | -88.2% | 2,500 | -73.9% | 0.00% | – |
Q1 2022 | $17,000 | +30.8% | 9,591 | +11.6% | 0.00% | – |
Q4 2021 | $13,000 | +85.7% | 8,591 | +140.4% | 0.00% | – |
Q3 2021 | $7,000 | -61.1% | 3,573 | -32.1% | 0.00% | – |
Q2 2021 | $18,000 | +350.0% | 5,259 | +110.4% | 0.00% | – |
Q1 2021 | $4,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
Freed Investment Group | 14,600 | $26,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
LMR Partners LLP | 63,950 | $114,000 | 0.00% |
Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |